9 SEPTEMBER 2010 NEW ZEALAND GAZETTE, No. 115 3091

Product: Abilify ODT
Active Ingredient: Aripiprazole 20mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico

Product: Abilify ODT
Active Ingredient: Aripiprazole 30mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico

Product: Nicorette Inhaler
Active Ingredient: Nicotine 15mg
Dosage Form: Volatile liquid for inhalation
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: McNeil AB, Helsingborg, Sweden

Product: Tykerb
Active Ingredient: Lapatinib ditosilate 405mg equivalent to 250mg lapatinib free base
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Glaxo Operations UK Limited (t/a Glaxo Wellcome Operations), Hertfordshire, United Kingdom

Dated this 3rd day of September 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7059

Amendment—Classification of Medicines

Pursuant to section 106(1) of the Medicines Act 1981, I, Janice Wilson, Deputy Director-General, Population Health Directorate, Ministry of Health, acting under delegated authority, hereby declare the following:

The medicine listed in Schedule 1 to this notice is classified as a prescription medicine.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

(a) preparations and admixtures containing any proportion of any substance listed in the notice.
(b) salts and esters of any substance listed in the notice.
(c) preparations or extracts of biological materials listed in the notice.
(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and
(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1
Prescription Medicines

Oseltamivir; except when sold in a pharmacy between the months of April to November inclusive by a registered pharmacist who is satisfied that the medicine is for the treatment of a consumer who is resident in New Zealand, is 12 years of age or more, and currently has the symptoms of influenza.

This notice updates the notice in respect of Oseltamivir that was published in the New Zealand Gazette, 1 April 2010, No. 39, page 1109.

Dated this 4th day of September 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health.

go7078

Internal Affairs

Marriage Act 1955

Marriage (Approval of Organisations) Notice No. 21

Pursuant to the Marriage Act 1955, the Registrar-General of Marriages hereby gives notice as follows.

Notice

1. This notice may be cited as the Marriage (Approval of Organisations) Notice No. 21.

2. The organisations specified in the Schedule hereto are hereby declared to be approved organisations for the purpose of the Marriage Act 1955.

Schedule

• Bethel Living Christian Centre.
• Doxa Deo.
• Hansarang Church.

Dated at Wellington this 9th day of September 2010.

B. E. CLARKE, Registrar-General.

go7040